Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
FLRY3.SA
Strong BuyFull HouseFLAGFleury S.A. · Healthcare · Brazil · $2.0B · Avg Vol: $19M/d
Stock passes eligibility (Quality 60, Value 80, Momentum 77). However, no confirming signals like insider buying or significant EPS revisions exist to overcome the inherent volatility of emerging market healthcare exposure.
COMPANY DESCRIPTION
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.5B | 6.5B | 7.7B | 8.3B | 22.9% | 8.9B | 9.2B | 9.8B | 8.8% |
| EPS (BRL) | 0.95 | 0.87 | 1.13 | 1.12 | 5.5% | 1.17 | 1.34 | 1.54 | 17.1% |
| Shares | 384.7M | 545.0M | 544.3M | 545.0M | +41.7% | 543.6M | — | — | — |
| Debt | 3.7B | 4.2B | 5.4B | 5.3B | 12.7% | 5.5B | — | — | — |
| Equity | 2.7B | 5.1B | 5.3B | 5.0B | 23.1% | — | — | — | — |
| Op CF | 987.1M | 1.4B | 1.9B | 2.1B | 29.3% | 2.3B | — | — | — |
| Inv CF | -1.4B | -17.1M | -2.1B | -516.1M | — | — | — | — | — |
| Fin CF | 380.9M | -1.4B | 126.0M | -1.6B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of FLRY3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| FLRY3.SA | Fleury S.A.(you) | $2.0B | 99 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $600M | 57 | Hold |
| HYPE3.SA | Hypera S.A. | $2.9B | 97 | Strong Buy |
| SAUD3.SA | Bradsaúde S.A. | $7.9B | 98 | Strong Buy |
| AALR3.SA | Alliança Saúde e Participações S.A. | $92M | 27 | Sell |
| MATD3.SA | Hospital Mater Dei S.A. | $317M | 95 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $343M | 93 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 97 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $404M | 87 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $177M | 97 | Strong Buy |
Peer medians: ROE 10.4% · P/E 13.0x · Gross margin 30.7%